Aclaris Therapeutics Inc. Comparables

Find the most relevant public market comparables for Aclaris Therapeutics Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.

Business Model

Clinical-stage biopharmaceutical company developing and commercializing therapies for immuno-inflammatory diseases. Also provides contract research services.

Target Customers

Patients with immuno-inflammatory diseases; pharmaceutical companies (for contract research).

Specific Focus

Developing novel drug candidates for immuno-inflammatory diseases, with a focus on underserved conditions.

Location

Wayne, Pennsylvania

CEO

Dr. Neal Walker

Industry

Life sciences

Sub Sector

Biopharmaceutical

3yr Revenue Growth

382%

Public Market Comparables

Below are the key valuation metrics for companies similar to Aclaris Therapeutics Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Aclaris Therapeutics Inc.? Our platform provides detailed analysis of Aclaris Therapeutics Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Aclaris Therapeutics Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Aclaris Therapeutics Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Aclaris Therapeutics Inc. Compset

As a leading player in the Life sciences industry within the Biotechnology sector, Aclaris Therapeutics Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Aclaris Therapeutics Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Aclaris Therapeutics Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free